Back to All

PharmaVOICE 2020 Year in Preview features precision medicine insight of CEO of Diaceutics Peter Keeling

28 November, 2019

The thought leadership of Peter Keeling, the CEO of Diaceutics, is featured in the PharmaVOICE’s 2020 Year in Preview issue (Nov/Dec 2019). Keeling is one of 130+ precision medicine experts selected to comment on 20 provocative questions regarding changes needed to “address inefficiency and productivity to achieve aspirational goals for healthcare in the future.” 

Keeling’s insight into the future possibilities for precision medicine is featured on page 32 in the opening article, entitled “The Year Ahead.” Keeling responded to the question “What if the promise of personalized medicine was realized?” with the following:

The following quote from Keeling is featured on page 85 in the article entitled “Patient Care: Treatment to Cure,” under “Early detection key to improving health” sidebar:

For more insights on and predictions for Precision Medicine in the year ahead, read the Diaceutics PM Readiness Report. 

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.